Labiana Health (XMAD:LAB) Price-to-Operating-Cash-Flow : (As of Jun. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Labiana Health's share price is €2.36. Labiana Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00. Hence, Labiana Health's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Labiana Health's Price-to-Operating-Cash-Flow or its related term are showing as below:

XMAD:LAB's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.105
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Labiana Health's Cash Flow from Operations per share for the six months ended in Dec. 2022 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00.

Labiana Health Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Labiana Health's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Price-to-Operating-Cash-Flow Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

5.19

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Price-to-Operating-Cash-Flow	-	-	-	5.19

Competitive Comparison of Labiana Health's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Labiana Health's Price-to-Operating-Cash-Flow falls into.

Labiana Health Price-to-Operating-Cash-Flow Calculation

Labiana Health's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.36	/	0
	=

Labiana Health's Share Price of today is €2.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labiana Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Labiana Health Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Labiana Health's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.